欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0991/002
药品名称TAFLOTAN sine 15 Mikrogramm/ml Augentropfen im Einzeldosisbehältnis
活性成分
    • tafluprost 15.0 mg/ml
剂型Eye drops, solution
上市许可持有人Santen Oy Niittyhaankatu 20 FIN-33720 Tampere Finland
参考成员国 - 产品名称Germany (DE)
TAFLOTAN sine 15 Mikrogramm/ml Augentropfen im Einzeldosisbehältnis
互认成员国 - 产品名称
    • Hungary (HU)
      TAFLOTAN 15 mikrogramm/ml oldatos szemcsepp
    • Cyprus (CY)
      SAFLUTAN EYE DROPS SOLUTION
    • Slovenia (SI)
    • Malta (MT)
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Saflutan 15 Mikrogramm/ml Augentropfen im Einzeldosisbehältnis
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Taftolan
    • Czechia (CZ)
    • Netherlands (NL)
    • Iceland (IS)
      Taflotan 15 míkróg/ml Augndropar, lausn
    • Portugal (PT)
    • Latvia (LV)
    • Lithuania (LT)
      TAFLOTAN 15 mikrogramų/ml akių lašai, tirpalas vienadozėje talpyklėje
    • Estonia (EE)
      TAFLOTAN
    • Bulgaria (BG)
      Taflotan
    • Romania (RO)
      Saflutan 15 micrograme/ ml picaturi oftalmice, solutie, fiolă unidoză
    • Slovakia (SK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Ireland (IE)
    • France (FR)
    • Greece (GR)
      SAFLUTAN
许可日期2008/03/19
最近更新日期2024/05/08
药物ATC编码
    • S01EE05 tafluprost
申请类型
  • TypeLevel1:New Active Substance
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase